Home » Topics » BioWorld Science

BioWorld Science
RSS

Improved prevention of CINV found with a palonosetron combination therapy

June 21, 2004

Antisense morpholino-oligomers inhibit coronavirus proliferation and growth

June 21, 2004

Savient updates recent developments

June 21, 2004

Non-antibacterial macrolides with potential as antiiflammatory agents

June 18, 2004

Novel IL-8 receptor antagonists and their use described by GSK

June 18, 2004

New CDK inhibitors in early development at Banyu

June 18, 2004

Takeda claims novel neurotrophic factor production enhancers

June 18, 2004

New macrolides able to potentiate the activity of antifungal azoles

June 18, 2004

New indole-based androgenic agents covered by Akzo Nobel patent

June 18, 2004

Antiangiogenic HARP-derived peptides newly developed at CNRS

June 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...